How Can Epigenomics Improve Risk Assessment in Toxicology?
Incorporating epigenomics into toxicological assessments can improve the understanding of how low-dose or chronic exposure to toxins affects health. By identifying epigenetic biomarkers that are indicative of exposure or early signs of disease, researchers can enhance risk assessment models and develop more targeted interventions. This can lead to more personalized approaches in public health and regulatory policies.
